Physician profile
Michael W Higgins
NPI 1538134903
$3,074.94
in general payments reported to CMS, 2019-2025
8 companies · $85.29 in 2025
The $85.29 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $80.14 · 2021: $190 · 2023: $2,491 · 2024: $79.79 · 2025: $85.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,145 · Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,145.10 |
| Food and Beverage | $510.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $2,356.29 | 2023 | Amistem |
| Stryker Corporation | $557.19 | 2019-2025 | Gamma, Accolade |
| Linvatec Corporation | $60.71 | 2024 | 5ms, Colink Afx, Allograft Tissue |
| Bioventus LLC | $36.06 | 2020-2023 | Supartz Fx Sodium Hyaluronate |
| Aroa Biosurgery Incorporated | $22.51 | 2025 | |
| Orthofix Medical, INC. | $19.08 | 2024 | Physio-Stim |
| Medical Device Business Services, INC. | $15.00 | 2020 | |
| Stability Biologics, LLC | $8.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.